{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:46:32Z","timestamp":1795139192544,"version":"4.10.3"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The rise of nonfentanyl synthetic opioids such as brorphine highlights the dynamic evolution of illicit opioid markets and the persistent toxicological and public health risks they pose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Studies reporting the pharmacology, toxicology, and analytical detection of brorphine and its analogues were identified through systematic searches of PubMed and Scopus databases. Additional data from official international organizations' early-warning platforms were also included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Brorphine acts as a potent \u03bc-opioid receptor agonist with preclinical evidence of strong antinociceptive activity, respiratory depression, and abuse potential. Since 2019, it has been increasingly identified in forensic casework, frequently in combination with fentanyl or benzodiazepines, and implicated in multiple nonfatal and fatal intoxications. Structurally related analogues, including halogenated derivatives and \u201corphine-type\u201d compounds, whose pharmacological properties and toxicological profiles are not well understood, have emerged. Although several liquid chromatography coupled with mass spectrometry\u2013based methods exist for brorphine detection, no validated analytical workflows or certified reference materials are currently available for its analogues, limiting comprehensive monitoring and biomonitoring capacity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The rapid spread of brorphine and its analogues underscores the ongoing transition from fentanyl derivatives toward novel nonfentanyl \u03bc-opioid receptor agonists. These substances pose significant analytical and toxicological challenges and require increased international surveillance, improved laboratory capabilities, and coordinated public health responses to reduce their impact.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001446","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T05:01:29Z","timestamp":1770008489000},"page":"424-431","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Brorphine and Its Analogues: Pharmacology, Toxicology, and Biomonitoring"],"prefix":"10.1097","volume":"48","author":[{"given":"Emilia","family":"Marchei","sequence":"first","affiliation":[{"name":"National Center on Addiction and Doping, National Institute of Health, Rome, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Graziano","sequence":"additional","affiliation":[{"name":"National Center on Addiction and Doping, National Institute of Health, Rome, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pichini","sequence":"additional","affiliation":[{"name":"National Center on Addiction and Doping, National Institute of Health, Rome, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mag\u00ed","family":"Farr\u00e9","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Therapeutics and Toxicology, Universitat Aut\u00f2noma de Barcelona and Hospital-Institut de Recerca Germans Trias i Pujol (UAB-HUGTP-IGTP), Cerdanyola del Valles and Badalona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"R1-20261114","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1021\/acschemneuro.1c00037","article-title":"DARK classics in chemical neuroscience: etonitazene and related benzimidazoles","volume":"12","author":"Ujv\u00e1ry","year":"2021","journal-title":"ACS Chem Neurosci."},{"key":"R2-20261114","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/ADM.0000000000000324","article-title":"Misuse of novel synthetic opioids: a deadly new trend","volume":"11","author":"Prekupec","year":"2017","journal-title":"J Addict Med."},{"key":"R3-20261114","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/jat\/bkaa115","article-title":"A 2017-2019 update on acute intoxications and fatalities from illicit fentanyl and analogs","volume":"45","author":"Brunetti","year":"2021","journal-title":"J Anal Toxicol."},{"key":"R4-20261114","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1007\/s00204-020-02855-7","article-title":"In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances","volume":"94","author":"Vandeputte","year":"2020","journal-title":"Arch Toxicol."},{"key":"R5-20261114","doi-asserted-by":"crossref","first-page":"111775","DOI":"10.1016\/j.forsciint.2023.111775","article-title":"Non-fentanyl new synthetic opioids \u2013 an update","volume":"349","author":"Zawilska","year":"2023","journal-title":"Forensic Sci Int."},{"key":"R6-20261114","doi-asserted-by":"crossref","first-page":"110113","DOI":"10.1016\/j.neuropharm.2024.110113","article-title":"Elucidating the harm potential of brorphine analogues as new synthetic opioids: synthesis, in vitro, and in vivo characterization","volume":"260","author":"Vandeputte","year":"2024","journal-title":"Neuropharmacology"},{"key":"R7-20261114","doi-asserted-by":"crossref","first-page":"8895","DOI":"10.1021\/acs.jmedchem.8b01136","article-title":"Optimization of a series of mu opioid receptor (MOR) agonists with high G protein signaling bias","volume":"61","author":"Kennedy","year":"2018","journal-title":"J Med Chem."},{"key":"R8-20261114","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/1556-4029.14623","article-title":"Brorphine-investigation and quantitation of a new potent synthetic opioid in forensic toxicology casework using liquid chromatography-mass spectrometry","volume":"66","author":"Krotulski","year":"2021","journal-title":"J Forensic Sci."},{"key":"R9-20261114","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/jat\/bkaa094","article-title":"First report on brorphine: the next opioid on the deadly new psychoactive substance horizon?","volume":"44","author":"Verougstraete","year":"2021","journal-title":"J Anal Toxicol."},{"key":"R15-20261114","first-page":"bkab082","article-title":"The rise and fall of isotonitazene and brorphine: two recent stars in the synthetic opioid firmament","author":"Vandeputte","year":"2021","journal-title":"J Anal Toxicol."},{"key":"R16-20261114","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1007\/s00204-024-03774-7","article-title":"In vitro structure-activity relationships and forensic case series of emerging 2-benzylbenzimidazole \u2018nitazene\u2019 opioids","volume":"98","author":"Pottie","year":"2024","journal-title":"Arch Toxicol."},{"key":"R17-20261114","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/FTD.0000000000000970","article-title":"Acute intoxications and fatalities associated with benzimidazole opioid (nitazene analog) use: a systematic review","volume":"44","author":"Montanari","year":"2022","journal-title":"Ther Drug Monit."},{"key":"R18-20261114","doi-asserted-by":"crossref","first-page":"12332","DOI":"10.3390\/ijms252212332","article-title":"Evaluation of short-term stability of different nitazenes psychoactive opioids in dried blood spots by liquid chromatography-high-resolution mass spectrometry","volume":"25","author":"Vitrano","year":"2024","journal-title":"Int J Mol Sci."},{"key":"R19-20261114","first-page":"93","article-title":"Fentanyl and other new psychoactive synthetic opioids. Challenges to prevention and treatment","volume":"75","author":"Albores-Garc\u00eda","year":"2023","journal-title":"Rev Invest Clin."},{"key":"R20-20261114","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.367.6481.966","article-title":"Safety benefits of \u2018biased\u2019 opioids scrutinized","volume":"367","author":"Servick","year":"2020","journal-title":"Science"},{"key":"R21-20261114","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/pharmaceutics14010055","article-title":"Comparison of an addictive potential of \u03bc-opioid receptor agonists with G protein bias: behavioral and molecular modeling studies","volume":"14","author":"Kudla","year":"2021","journal-title":"Pharmaceutics"},{"key":"R22-20261114","doi-asserted-by":"crossref","first-page":"110989","DOI":"10.1016\/j.forsciint.2021.110989","article-title":"Pharmacological and metabolic characterization of the novel synthetic opioid brorphine and its detection in routine casework","volume":"327","author":"Grafinger","year":"2021","journal-title":"Forensic Sci Int."},{"key":"R23-20261114","doi-asserted-by":"crossref","first-page":"36703","DOI":"10.1074\/jbc.M113.504381","article-title":"Development of functionally selective, small molecule agonists at kappa opioid receptors","volume":"288","author":"Zhou","year":"2013","journal-title":"J Biol Chem."},{"key":"R24-20261114","doi-asserted-by":"crossref","first-page":"e70040","DOI":"10.1111\/dar.70040","article-title":"Behavioural effects and naloxone effectiveness with new synthetic opioids","volume":"45","author":"Nielsen","year":"2026","journal-title":"Drug Alcohol Rev."},{"key":"R25-20261114","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00228-021-03136-7","article-title":"Severe rhabdomyolysis and acute kidney failure due to synthetic opioid brorphine exposure in combination with chronic sertraline therapy","volume":"77","author":"Razinger","year":"2021","journal-title":"Eur J Clin Pharmacol."},{"key":"R26-20261114","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/15563650.2021.1879111","article-title":"Death associated with brorphine, an emerging novel synthetic opioid","volume":"59","author":"Vohra","year":"2021","journal-title":"Clin Toxicol (Phila)."},{"key":"R27-20261114","doi-asserted-by":"crossref","first-page":"e2331264","DOI":"10.1001\/jamanetworkopen.2023.31264","article-title":"Toxicology investigators consortium fentalog study group. Naloxone use in novel potent opioid and fentanyl overdoses in emergency department patients","volume":"6","author":"Amaducci","year":"2023","journal-title":"JAMA Netw Open."},{"key":"R28-20261114","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1021\/ac981310r","article-title":"Identification and quantitation of despropionyl-bezitramide in postmortem samples by liquid chromatography coupled to electrospray ionization tandem mass spectrometry","volume":"71","author":"De Baere","year":"1999","journal-title":"Anal Chem."},{"key":"R29-20261114","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/jox12040025","article-title":"Application of fabric phase sorptive extraction (FPSE) engaged to tandem LC-MS\/MS for quantification of brorphine in oral fluid","volume":"12","author":"Florou","year":"2022","journal-title":"J Xenobiot."},{"key":"R30-20261114","doi-asserted-by":"crossref","first-page":"115975","DOI":"10.1016\/j.jpba.2024.115975","article-title":"Method development for the quantification of nine nitazene analogs and brorphine in dried blood spots utilizing liquid chromatography \u2013 tandem mass spectrometry","volume":"241","author":"Ververi","year":"2024","journal-title":"J Pharm Biomed Anal."},{"key":"R31-20261114","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/1556-4029.15348","article-title":"Detection of fentanyl, synthetic opioids, and ketamine in hair specimens from purposive samples of American and Italian populations","volume":"68","author":"Salomone","year":"2023","journal-title":"J Forensic Sci."},{"key":"R32-20261114","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/PAF.0000000000000787","article-title":"Proliferation of novel synthetic opioids in postmortem investigations after core-structure scheduling for fentanyl-related substances","volume":"43","author":"Papsun","year":"2022","journal-title":"Am J Forensic Med Pathol."},{"key":"R33-20261114","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jat\/bkaa070","article-title":"Flualprazolam blood concentrations in 197 forensic investigation cases","volume":"45","author":"Papsun","year":"2021","journal-title":"J Anal Toxicol."},{"key":"R34-20261114","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/jat\/bkaa016","article-title":"Isotonitazene quantitation and metabolite discovery in authentic forensic casework","volume":"44","author":"Krotulski","year":"2020","journal-title":"J Anal Toxicol."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:00:27Z","timestamp":1794664827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001446","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"2025-12-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}